SOPH MEXC RealStocks
Own real SOPH shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:12:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
SOPHiA GENETICS SA (SOPH) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $7.47, with a market capitalization of $638.15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.83 to $8.98. This page covers its latest market performance, valuation, price trends and company information.
$638.15M | |
$7.46 | |
$7.64 | |
$7.38 | |
$7.45 | |
575.73K | |
658.36K | |
-- | |
$8.98 | |
$3.83 | |
-- | |
2026-09-30 |
SOPHiA GENETICS SA (SOPH) last closed at $7.47 as of 2026-11-19 00:31:00, up 0.07% ($0.00) from the previous close of $7.45.
During the latest regular trading session, SOPH traded between $7.38 and $7.64, with a volume of 575.73K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, SOPHiA GENETICS SA (SOPH) moved from $7.86 to $7.47, representing a decline of 5.03% ($0.40).
The stock traded between $7.12 and $8.32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 710.33 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.6%
SOPH is currently trading at $7.47, placing it 70.6% of the way from its 52-week low of $3.83 to its 52-week high of $8.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Employees | 415 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SOPHiA GENETICS SA (SOPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SOPH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SOPH shares and USD.
SOPH Shares to USD
1.00 SOPH shares = 7.465 USD
Calculations are estimates based on the latest available price and are for reference only.